Heron Therapeutics | HRTX - Market Capitalization


Heron Therapeutics reported $51.7M in Market Capitalization this September of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
ALKERMES USD 8.73B 2.85B Jun/2026
Alnylam Pharmaceuticals USD 40.19B 3.96B Jun/2026
Amarin USD 290M 51M Dec/2025
ANI Pharmaceuticals USD 1.88B 133M Jun/2026
Anika Therapeutics USD 139M 3M Dec/2025
Arrowhead Research USD 11.5B 2.72B Jun/2026
Eisai JPY 1.2T 219.32B Jun/2026
Emergent BioSolutions USD 125M 51M Dec/2023
GlaxoSmithKline GBP 80.14B 3.66B Jun/2026
Heron Therapeutics USD 238M 7M Dec/2025
Insmed USD 23.11B 12.19B Jun/2026
Ligand Pharmaceuticals USD 6.34B 2.35B Jun/2026
Merck USD 317.37B 20.27B Jun/2026
Nektar Therapeutics USD 2.12B 1.26B Mar/2026
Neurocrine Biosciences USD 16.95B 3.7B Jun/2026
Pacira USD 998M 83M Jun/2026
Regeneron Pharmaceuticals USD 65.37B 16.31B Jun/2026
Roche Holding CHF 270B 3.66B Jun/2026
Ultragenyx Pharmaceutical USD 3.29B 1.23B Jun/2026
Veracyte USD 4.69B 2.12B Jun/2026
Vertex Pharmaceuticals USD 126.07B 12.49B Jun/2026